AstraZeneca PLC (AZN.L, AZN) said, in 2021, its total revenue increased by 41% and core EPS grew by 32%. The Group noted that it delivered on promise of broad and equitable access to COVID-19 vaccine with 2.5 billion doses released for supply around the world. The Group is increasing the dividend for shareholders, and said it is confident in long term growth and profitability.
from RTT - Earnings https://ift.tt/m0XyChb
via IFTTT
No comments:
Post a Comment